Both in Pharmaceuticals
PMGC Holdings vs Kairos Pharma
Over the past year ELAB returned −99.8% and KAPA returned −93.4%; their daily moves had a correlation of 0.00.
ELAB −99.8% KAPA −93.4%Growth of $1, one year, split-adjusted
| Metric | ELAB | KAPA |
|---|---|---|
| Price | $2.57 | $0.5231 |
| Market cap | $2.1M | $1.8M |
| Today | −0.39% | −1.30% |
| 1 month | −30.0% | −68.5% |
| 6 months | −89.8% | −86.5% |
| Year to date | −99.3% | −89.5% |
| 1 year | −99.8% | −93.5% |
| Revenue growth (YoY) | — | — |
| Gross margin | 29.5% | — |
| Net margin | −225.1% | — |
| P/E (TTM) | — | — |
| Price / sales | 0.8× | — |
| Net cash | $9.4M | $2.6M |
| Dividend yield | — | — |
| Volatility (60d) | 676.5% | 581.5% |
| Short % of float | 0.4% | 0.9% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).